Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A0A3S7WZB6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 139 | 143 | PF00656 | 0.516 |
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.770 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.471 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.488 |
DOC_PP4_FxxP_1 | 127 | 130 | PF00568 | 0.551 |
DOC_PP4_FxxP_1 | 53 | 56 | PF00568 | 0.671 |
DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.677 |
LIG_14-3-3_CanoR_1 | 3 | 10 | PF00244 | 0.694 |
LIG_14-3-3_CanoR_1 | 45 | 54 | PF00244 | 0.679 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.545 |
LIG_BRCT_BRCA1_1 | 49 | 53 | PF00533 | 0.674 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.670 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.542 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.711 |
LIG_LIR_Apic_2 | 50 | 56 | PF02991 | 0.670 |
LIG_LIR_Apic_2 | 68 | 72 | PF02991 | 0.629 |
LIG_LIR_Gen_1 | 142 | 153 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 142 | 148 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.653 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.639 |
LIG_PDZ_Class_3 | 151 | 156 | PF00595 | 0.440 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.726 |
LIG_SH2_STAP1 | 61 | 65 | PF00017 | 0.643 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.631 |
LIG_SH3_3 | 143 | 149 | PF00018 | 0.516 |
LIG_SUMO_SIM_par_1 | 99 | 108 | PF11976 | 0.680 |
LIG_TRFH_1 | 126 | 130 | PF08558 | 0.355 |
LIG_UBA3_1 | 103 | 111 | PF00899 | 0.671 |
MOD_CK1_1 | 136 | 142 | PF00069 | 0.513 |
MOD_DYRK1A_RPxSP_1 | 48 | 52 | PF00069 | 0.674 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.659 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.389 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.508 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.665 |
MOD_PKA_1 | 3 | 9 | PF00069 | 0.722 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.698 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.679 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.450 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.664 |
MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.676 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.347 |
TRG_NLS_Bipartite_1 | 93 | 113 | PF00514 | 0.644 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8V9 | Leptomonas seymouri | 87% | 100% |
A0A0S4JP84 | Bodo saltans | 63% | 100% |
A0A1X0NYC2 | Trypanosomatidae | 76% | 100% |
A0A3R7P4M5 | Trypanosoma rangeli | 75% | 100% |
A4HEB1 | Leishmania braziliensis | 91% | 100% |
A4I1Q7 | Leishmania infantum | 100% | 100% |
C9ZKB2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
E9AXU1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q9N0 | Leishmania major | 99% | 100% |